noscript

News and Announcements

Prescient Therapeutics Secures $7.0M Capital Raising

  • Published May 18, 2016 4:26PM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

18th May 2016, ASX Announcement

  • $7.0 M institutional placement
  • Rights issue on same terms to raise up to a further $3.4 M

Prescient Therapeutics Limited (ASX: PTX), a clinical stage oncology company, is pleased to advise the successful completion of of an institutional placement to raise $7.0 million.

The placement, largely to life-science focused Australian institutional investors, has been undertaken which will involve the issue of approximately 77.7 million shares at 9.0 cents per share with 1 attaching option for every 2 shares subscribed (exercisable at 18 cents; expiring 30 June 2018). The placement will be undertaken in two tranches. The first tranche of approximately 19.4 million shares will be unconditional, with shareholders to approve the second tranche (of approximately 58.3 million) and all attaching options.

To view the full announcement, please click on the button below.

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now